Market outlook of the global immunoprotein diagnostic testing market
Immunoproteins are blood proteins that are used as analytes for different disease diagnostic assays like ELISA, CLIA, immunoturbidity assay, and RIA. The market for immunoprotein diagnostic testing is positively influenced by factors like the growing elderly population and the increased incidence and prevalence of chronic diseases. These factors foster the prospects for growth in this market and results in its healthy CAGR of more than 7% by 2019.
Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Advantages like its ability to reduce the total healthcare expenditure and its ability to reduce the recovery time of patients are expected to impel market growth during the forecast period.
Application-based segmentation of the immunoprotein diagnostic testing market
• Infectious disease testing
• Oncology and endocrine testing
• Autoimmune testing
• Allergy testing
Technavios market research analyst has estimated the infectious disease testing segment to be the largest market segment during the forecast period. The high incidence of infectious diseases is expected to result in the augmented need for novel diagnostic tests and new reagents. This recent increase in the incidence of infectious diseases is expected to result in the augmented demand for immunoprotein diagnostic tests as it helps in the early diagnosis of infectious ailments.
Geographical segmentation of the immunoprotein diagnostic testing market
• APAC
• EMEA
• Americas
In this market research report, analysts estimate the Americas to dominate the market for immunoprotein diagnostic testing during the forecast period. In the Americas, the US is considered to be the largest revenue contributor due to the high prevalence of chronic and infectious diseases in this region. Factors like the rise in laboratory automation, shift to POC rapid diagnostic tests, and increased FDA approval for new products are envisaged to account for this regions high market share of nearly 46% by 2019.
Competitive landscape and key vendors
This market is characterized by the presence of intense competition between numerous large, medium, and small-sized manufacturers that provide different type of immunoprotein diagnostic products based on technologies like ELISA, RIA, and CLIA. These vendors form partnerships and provide premium-priced products to laboratories and patients so as to establish themselves in the market.
Leading vendors in this market are -
• Beckman Coulter
• Diasorin
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
Other prominent vendors analyzed in this global market study are Abbott Laboratories, Affymetrix, Alere, bioMérieux, Bio-Rad Laboratories, Corgenix, Dako, Fujirebio Diagnostics, Merck Millipore, Meridian Bioscience, ORGENTEC Diagnostika, Sekisui Diagnostics, IBL International, ImmunoDX, Quidel Corporation, and Trinity Biotech.
Key questions answered in the report include
• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global immunoprotein diagnostic testing market?
• What are the key market trends impacting the global immunoprotein diagnostic testing market?
• What are the challenges to market growth?
• Who are the key vendors in the global immunoprotein diagnostic testing market?
• What are the market opportunities and threats faced by the vendors in the global immunoprotein diagnostic testing market?
• Trending factors influencing the market shares of the EMEA, Americas, and APAC?
• What are the key outcomes of the five forces analysis of the global immunoprotein diagnostic testing market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
• Global Bone and Mineral Diagnostic Testing Market 2015-2019
• Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019
• Global In-vitro Diagnostics Infectious Disease Testing Market 2015-2019
PART 01:Executive summary
Highlights
PART 02:Scope of the report
Market overview
Top-vendor offerings
Instruments
Assays
Instrument
Assays
Instruments
Assays
Instruments
Assays
PART 03:Market research methodology
Research methodology
Economic indicators
PART 04:Introduction
Key market highlights
PART 05:Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06:Market segmentation by application
Global immunoprotein diagnostic testing market by application 2015-2019
Infectious disease
Market size and forecast
Oncology and endocrinology testing
Market size and forecast
Autoimmune testing
Market size and forecast
Allergy testing
Market size and forecast
PART 07:Geographical segmentation
Immunoprotein diagnostic testing market in Americas
Market size and forecast
Immunoprotein diagnostic testing market in EMEA
Market size and forecast
Immunoprotein diagnostic testing market in APAC
Market size and forecast
PART 08:Market drivers
Rise in incidence of chronic and infectious diseases
Focus on early disease diagnosis
Increased usage of POC test kits
PART 09:Impact of drivers
PART 10:Market challenges
Limited detection capability and complexity
High cost of upgradation
Lack of skilled technicians
PART 11:Impact of drivers and challenges
PART 12:Market trends
Development in automation of assay system
Increasing usage of multiplex bead-based assays
Growing focus on emerging countries
PART 13:Vendor landscape
Competitive scenario
Key news
Mergers and acquisitions
Market share analysis 2014
Beckman Coulter
Diasorin
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific
Other prominent vendors
PART 14:Key vendor analysis
Beckman Coulter
Business overview
Business segmentation
Beckman Coulter in invitro diagnostic (IVD) sector
Recent developments
DiaSorin
Business overview
Business segmentation
Business segmentation by revenue 2013 and 2014
Geographical segmentation by revenue 2014
DiaSorin in in-vitro diagnostics
Recent developments
Roche Diagnostics
Business overview
Product segmentation
Business segmentation by revenue 2014
Business segmentation by revenue 2013 and 2014
Geographical segmentation by revenue 2014
Recent developments
Siemens Healthcare
Business overview
Business segmentation
Geographical segmentation by revenue 2014
Siemens Healthcare in diagnostics sector
Recent developments
Thermo Fisher Scientific Inc
Business overview
Business segmentation
Business segmentation by revenue 2014
Business segmentation by revenue 2013 and 2014
Geographical segmentation by revenue 2014
Recent developments
PART 15:Appendix
List of abbreviation
PART 16:Explore Technavio
Exhibit 01:Product offerings8
Exhibit 02:Global immunoprotein diagnostic testing market 2014-2019 ($ billions)
Exhibit 03:Five forces analysis
Exhibit 04:Segmentation of global immunoprotein diagnostic testing market by application
Exhibit 05:Segmentation of global immunoprotein diagnostic testing market by application 2014
Exhibit 06:Global infectious disease diagnostic testing market 2014-2019
Exhibit 07:Global oncology and endocrinologyendocrine immunoprotein diagnostic testing market 2014-2019
Exhibit 08:Global autoimmune immunoprotein diagnostic testing market 2014-2019
Exhibit 09:Global allergy immunoprotein diagnostic testing market 2014-2019
Exhibit 10:Segmentation of global immunoprotein diagnostic testing market by geography 2014
Exhibit 11:Segmentation of global immunoprotein diagnostic testing market by geography 2019
Exhibit 12:Segmentation of global infectious disease diagnostic testing market by geography 2014-2019
Exhibit 13:Immunoprotein diagnostic testing market in Americas 2014-2019 ($ billions)
Exhibit 14:Immunoprotein diagnostic testing market in EMEA 2014-2019 ($ billions)
Exhibit 15:Immunoprotein diagnostic testing market in APAC 2014-2019 ($ billions)
Exhibit 16:Impact of drivers
Exhibit 17:Impact of drivers and challenges
Exhibit 18:Key takeaways: Diasorin
Exhibit 19:Key takeaways: Roche Diagnostics
Exhibit 20:Key takeaways: Siemens Healthcare
Exhibit 21:Key takeaways: Thermo Fisher Scientific
Exhibit 22:Beckman Coulter: Business segmentation
Exhibit 23:DiaSorin: Business segmentation by revenue 2014
Exhibit 24:DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 25:DiaSorin: Geographical segmentation by revenue 2014
Exhibit 26:Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 27:Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28:Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 29:Siemens Healthcare: Business segmentation
Exhibit 30:Siemens Healthcare: Geographical segmentation by revenue 2014
Exhibit 31:Thermo Fisher: Brands
Exhibit 32:Thermo Fisher: Business segmentation by revenue 2014
Exhibit 33:Thermo Fisher: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 34:Thermo Fisher: Geographical segmentation by revenue 2014
